Skip to main content
. 2019 Sep 12:415–423. doi: 10.1016/B978-0-12-409548-9.11870-6

Table 1.

The efficacy of first-, second-, and third-line H. pylori eradication therapies

Therapy Regimen Number treated Number successful Success (%) Bacteriolytic in regimen
First-line theraphy PPI-based regimens 364 243 66.8 Amoxicillin, nitromidazole, clarithromycin, erythromycin, and tetracycline
Bi-based regimens 105 100 95.2 Amoxicillin, nitroimidazole, and clarithromycin
Second-line therapy PPI-based regimens 16 6 37.5 Nitroimidazole, amoxicillin, and clarithromycin
Bi-based regimens 50 36 72.0 Nitroimidazole, tetracycline, amoxicillin, and clarithromycin
Third-line therapy Other regimens 14 8 57.1 Omeprazole, rifabutin, and amoxicillin
Bi-based regimens 6 5 83.3 Clarithromycin, tetracycline, and tinidazole